Use of the Corus® CAD Gene Expression Test for Assessment of Obstructive Coronary Artery Disease Likelihood in Symptomatic Non-Diabetic Patients
Conclusions
The Corus CAD test has been extensively evaluated since it was first derived, including with two prospective multi-center trials. Given the scope of the deleterious effects of CAD and the considerable costs involved in diagnosing obstructive CAD, a blood test that can help in this determination is certainly valuable. The Corus CAD test promises to have an important role in this regard particularly if it continues to perform this well in larger, more diverse cohorts.
Source: PLOS Currents Evidence on Genomic Tests - Category: Genetics & Stem Cells Authors: Jose Vargas Source Type: research
More News: Anatomy | Angiography | Autoimmune Disease | Cardiac Catheterization | Cardiology | Cardiovascular | Chronic Pain | Clinical Trials | Diabetes | Diabetes Mellitus | Endocrinology | Genetics | Health Management | Heart | Heart Attack | Heart Failure | Hemorrhagic Stroke | History of Medicine | International Medicine & Public Health | Laboratory Medicine | Medicare | Molecular Biology | Pain | Pain Management | Pathology | Perfusion | PET Scan | Primary Care | Primary Care Practices | Statistics | Stroke | Study | Women